Patents Assigned to Aventis Pasteur, Ltd.
  • Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
    Publication number: 20070031852
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Application
    Filed: December 30, 2004
    Publication date: February 8, 2007
    Applicant: Aventis Pasteur Ltd
    Inventors: Lynn Doucette-Stamm, David Bush, Qiandong Zeng, Timothy Opperman, Chad Houseweart
  • Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
    Publication number: 20070009905
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Application
    Filed: December 30, 2004
    Publication date: January 11, 2007
    Applicant: Aventis Pasteur Ltd.
    Inventors: Lynn Doucette-Stamm, David Bush, Qiandong Zeng, Timothy Opperman, Chad Houseweart
  • Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
    Publication number: 20070009903
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Application
    Filed: December 30, 2004
    Publication date: January 11, 2007
    Applicant: Aventis Pasteur Ltd
    Inventors: Lynn Doucette-Stamm, David Bush, Qiandong Zeng, Timothy Opperman, Chad Houseweart
  • Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
    Publication number: 20070009900
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Application
    Filed: December 30, 2004
    Publication date: January 11, 2007
    Applicant: Aventis Pasteur Ltd
    Inventors: Lynn Doucette-Stamm, David Bush, Qiandong Zeng, Timothy Opperman, Chad Houseweart
  • Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
    Publication number: 20070009904
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Application
    Filed: December 30, 2004
    Publication date: January 11, 2007
    Applicant: Aventis Pasteur Ltd
    Inventors: Lynn Doucette-Stamm, David Bush, Qiandong Zeng, Timothy Opperman, Chad Houseweart
  • Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
    Publication number: 20070009901
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Application
    Filed: December 30, 2004
    Publication date: January 11, 2007
    Applicant: Aventis Pasteur Ltd
    Inventors: Lynn Doucette-Stamm, David Bush, Qiandong Zeng, Timothy Opperman, Chad Houseweart
  • Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
    Publication number: 20070009906
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Application
    Filed: December 30, 2004
    Publication date: January 11, 2007
    Applicant: Aventis Pasteur Ltd
    Inventors: Lynn Doucette-Stamm, David Bush, Qiandong Zeng, Timothy Opperman, Chad Houseweart
  • Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
    Publication number: 20070009902
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Application
    Filed: December 30, 2004
    Publication date: January 11, 2007
    Applicant: Aventis Pasteur Ltd.
    Inventors: Lynn Doucette-Stamm, David Bush, Qiandong Zeng, Timothy Opperman, Chad Houseweart
  • Tumor antigen BFA5 for prevention and / or treatment of cancer
    Publication number: 20050112099
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: April 15, 2004
    Publication date: May 26, 2005
    Applicant: Aventis Pasteur, Ltd.
    Inventors: Neil Berinstein, Scott Gallichan, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Devender Singh-Sandhu
  • Vaccines using high-dose cytokines
    Publication number: 20040223949
    Abstract: The present invention relates to the field of cancer immunotherapy. In particular, vaccines are administered in conjunction with high doses of cytokines to enhance an anti-tumor immune response.
    Type: Application
    Filed: October 21, 2003
    Publication date: November 11, 2004
    Applicant: Sunnybrook and Women's College Health Sciences Center Aventis Pasteur, Ltd.
    Inventors: Igor Astsaturov, Teresa Petrella, Mark DeBenedette, Neil Berinstein, David E. Spaner
  • Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
    Publication number: 20040197912
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: July 1, 2003
    Publication date: October 7, 2004
    Applicant: Aventis Pasteur, Ltd.
    Inventors: Neil Berinstein, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Scott Gallichan, Devender Singh-Sandhu, Raymond P. Oomen, Shi-Xian Cao
  • Targeted immunogens
    Publication number: 20040002455
    Abstract: The present invention provides reagents and methods for producing and utilizing targeted immunogens. In preferred embodiments, an immunogen is conjugated to an amino acid sequence that targets the immunogen to the MHC presentation pathway. Using the reagents and methods provided herein, immunization protocols may be enhanced resulting in increased immunity of the host.
    Type: Application
    Filed: January 29, 2003
    Publication date: January 1, 2004
    Applicants: Aventis Pasteur, Ltd., Aventis Pharmaceuticals, Inc.
    Inventors: Robert Adam Uger, Danielle Salha, Brian Barber, Clarence C. Morse, Yong Guo, Su Cheng
  • Immunogenic targets for melanoma
    Publication number: 20030113919
    Abstract: The present invention relates to peptides, polypeptides, and nucleic acids and the use of the peptide, polypeptide or nucleic acid in preventing and/or treating cancer. In particular, the invention relates to peptides and nucleic acid sequences encoding such peptides for use in diagnosing, treating, or preventing melanoma.
    Type: Application
    Filed: August 15, 2002
    Publication date: June 19, 2003
    Applicant: Aventis Pasteur, Ltd.
    Inventors: Peter Emtage, Liza Karunakaran, Artur Pedyczak, Brian Barber